Genfit S.A. (EPA:GNFT)
5.10
-0.10 (-1.92%)
At close: Dec 12, 2025
Genfit Market Cap
Genfit has a market cap or net worth of €253.96 million as of December 12, 2025. Its market cap has increased by 35.28% in one year.
Market Cap
253.96M
Enterprise Value
285.36M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.10
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 253.96M, an increase of 73.86%. That is a compound annual growth rate of 2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 253.96M | 44.07% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | 154.93M | -77.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 131.38B |
| Sanofi | 101.77B |
| Sartorius Stedim Biotech | 20.18B |
| bioMérieux | 12.57B |
| Eurofins Scientific SE | 10.18B |
| Ipsen | 9.98B |
| ABIVAX Société Anonyme | 8.75B |
| Virbac | 2.85B |